![]() 世界および米国の小児用痙攣治療の市場規模、現状、予測2021-2027年Global and United States Paediatric Spasticity Treatment Market Size, Status and Forecast 2021-2027 小児の痙性は、自発的な動きを制御する脳や脊髄の一部が損傷することで生じます。怪我や病気により小児痙性が発生すると、神経信号が筋肉に届かず、筋肉が持続的に収縮して硬くなり、運動や会話に支障をきたすよ... もっと見る
![]()
※当ページの内容はウェブ更新時の情報です。
サマリー小児の痙性は、自発的な動きを制御する脳や脊髄の一部が損傷することで生じます。怪我や病気により小児痙性が発生すると、神経信号が筋肉に届かず、筋肉が持続的に収縮して硬くなり、運動や会話に支障をきたすようになります。市場分析と洞察世界の小児用痙縮治療市場 小児痙攣治療の世界市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX%のCAGRで、2027年にXX百万米ドルに達すると予測されます。 本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の小児痙攣治療市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つことを目的としています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には、収益面での世界の小児痙攣治療市場の全体的なサイズも含まれています。 本レポートは、世界の小児痙攣治療市場において競合他社よりも優位に立ち、永続的な成功を収めるための有効なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の小児痙攣治療市場を詳細に調査するために、独自の、そして業界で最も優れた調査・分析手法を用いています。 世界の小児用痙縮治療の範囲と市場規模 小児痙攣治療市場は、企業別、地域(国)別、タイプ別、アプリケーション別に分類されています。世界の小児痙攣治療市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年までの期間における、タイプ別、アプリケーション別の収益と予測に焦点を当てています。 タイプ別セグメント 薬物治療 外科的治療 アプリケーション別 病院 クリニック 救急医療センター その他 地域別 北アメリカ アメリカ カナダ ヨーロッパ ドイツ フランス イギリス イタリア ロシア 北欧 その他のヨーロッパ諸国 アジア太平洋地域 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア諸国 ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中近東・アフリカ トルコ サウジアラビア アラブ首長国連邦 その他の中東・アフリカ地域 会社別 アラガン イプセン・バイオファーマシューティカルズ Almirall ロシュ サノフィ Saol Therapeutics 米国 ワールドメド 目次1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Paediatric Spasticity Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Drug Treatment 1.2.3 Surgical Treatment 1.3 Market by Application 1.3.1 Global Paediatric Spasticity Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Emergency Sugical Center 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Paediatric Spasticity Treatment Market Perspective (2016-2027) 2.2 Paediatric Spasticity Treatment Growth Trends by Regions 2.2.1 Paediatric Spasticity Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Paediatric Spasticity Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Paediatric Spasticity Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Paediatric Spasticity Treatment Industry Dynamic 2.3.1 Paediatric Spasticity Treatment Market Trends 2.3.2 Paediatric Spasticity Treatment Market Drivers 2.3.3 Paediatric Spasticity Treatment Market Challenges 2.3.4 Paediatric Spasticity Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Paediatric Spasticity Treatment Players by Revenue 3.1.1 Global Top Paediatric Spasticity Treatment Players by Revenue (2016-2021) 3.1.2 Global Paediatric Spasticity Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Paediatric Spasticity Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Paediatric Spasticity Treatment Revenue 3.4 Global Paediatric Spasticity Treatment Market Concentration Ratio 3.4.1 Global Paediatric Spasticity Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Paediatric Spasticity Treatment Revenue in 2020 3.5 Paediatric Spasticity Treatment Key Players Head office and Area Served 3.6 Key Players Paediatric Spasticity Treatment Product Solution and Service 3.7 Date of Enter into Paediatric Spasticity Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Paediatric Spasticity Treatment Breakdown Data by Type 4.1 Global Paediatric Spasticity Treatment Historic Market Size by Type (2016-2021) 4.2 Global Paediatric Spasticity Treatment Forecasted Market Size by Type (2022-2027) 5 Paediatric Spasticity Treatment Breakdown Data by Application 5.1 Global Paediatric Spasticity Treatment Historic Market Size by Application (2016-2021) 5.2 Global Paediatric Spasticity Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Paediatric Spasticity Treatment Market Size (2016-2027) 6.2 North America Paediatric Spasticity Treatment Market Size by Type 6.2.1 North America Paediatric Spasticity Treatment Market Size by Type (2016-2021) 6.2.2 North America Paediatric Spasticity Treatment Market Size by Type (2022-2027) 6.2.3 North America Paediatric Spasticity Treatment Market Size by Type (2016-2027) 6.3 North America Paediatric Spasticity Treatment Market Size by Application 6.3.1 North America Paediatric Spasticity Treatment Market Size by Application (2016-2021) 6.3.2 North America Paediatric Spasticity Treatment Market Size by Application (2022-2027) 6.3.3 North America Paediatric Spasticity Treatment Market Size by Application (2016-2027) 6.4 North America Paediatric Spasticity Treatment Market Size by Country 6.4.1 North America Paediatric Spasticity Treatment Market Size by Country (2016-2021) 6.4.2 North America Paediatric Spasticity Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Paediatric Spasticity Treatment Market Size (2016-2027) 7.2 Europe Paediatric Spasticity Treatment Market Size by Type 7.2.1 Europe Paediatric Spasticity Treatment Market Size by Type (2016-2021) 7.2.2 Europe Paediatric Spasticity Treatment Market Size by Type (2022-2027) 7.2.3 Europe Paediatric Spasticity Treatment Market Size by Type (2016-2027) 7.3 Europe Paediatric Spasticity Treatment Market Size by Application 7.3.1 Europe Paediatric Spasticity Treatment Market Size by Application (2016-2021) 7.3.2 Europe Paediatric Spasticity Treatment Market Size by Application (2022-2027) 7.3.3 Europe Paediatric Spasticity Treatment Market Size by Application (2016-2027) 7.4 Europe Paediatric Spasticity Treatment Market Size by Country 7.4.1 Europe Paediatric Spasticity Treatment Market Size by Country (2016-2021) 7.4.2 Europe Paediatric Spasticity Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Paediatric Spasticity Treatment Market Size (2016-2027) 8.2 Asia-Pacific Paediatric Spasticity Treatment Market Size by Type 8.2.1 Asia-Pacific Paediatric Spasticity Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Paediatric Spasticity Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Paediatric Spasticity Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Paediatric Spasticity Treatment Market Size by Application 8.3.1 Asia-Pacific Paediatric Spasticity Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Paediatric Spasticity Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Paediatric Spasticity Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Paediatric Spasticity Treatment Market Size by Region 8.4.1 Asia-Pacific Paediatric Spasticity Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Paediatric Spasticity Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Paediatric Spasticity Treatment Market Size (2016-2027) 9.2 Latin America Paediatric Spasticity Treatment Market Size by Type 9.2.1 Latin America Paediatric Spasticity Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Paediatric Spasticity Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Paediatric Spasticity Treatment Market Size by Type (2016-2027) 9.3 Latin America Paediatric Spasticity Treatment Market Size by Application 9.3.1 Latin America Paediatric Spasticity Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Paediatric Spasticity Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Paediatric Spasticity Treatment Market Size by Application (2016-2027) 9.4 Latin America Paediatric Spasticity Treatment Market Size by Country 9.4.1 Latin America Paediatric Spasticity Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Paediatric Spasticity Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Paediatric Spasticity Treatment Market Size (2016-2027) 10.2 Middle East & Africa Paediatric Spasticity Treatment Market Size by Type 10.2.1 Middle East & Africa Paediatric Spasticity Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Paediatric Spasticity Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Paediatric Spasticity Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Paediatric Spasticity Treatment Market Size by Application 10.3.1 Middle East & Africa Paediatric Spasticity Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Paediatric Spasticity Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Paediatric Spasticity Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Paediatric Spasticity Treatment Market Size by Country 10.4.1 Middle East & Africa Paediatric Spasticity Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Paediatric Spasticity Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Allergan 11.1.1 Allergan Company Details 11.1.2 Allergan Business Overview 11.1.3 Allergan Paediatric Spasticity Treatment Introduction 11.1.4 Allergan Revenue in Paediatric Spasticity Treatment Business (2016-2021) 11.1.5 Allergan Recent Development 11.2 Ipsen Biopharmaceuticals 11.2.1 Ipsen Biopharmaceuticals Company Details 11.2.2 Ipsen Biopharmaceuticals Business Overview 11.2.3 Ipsen Biopharmaceuticals Paediatric Spasticity Treatment Introduction 11.2.4 Ipsen Biopharmaceuticals Revenue in Paediatric Spasticity Treatment Business (2016-2021) 11.2.5 Ipsen Biopharmaceuticals Recent Development 11.3 Almirall 11.3.1 Almirall Company Details 11.3.2 Almirall Business Overview 11.3.3 Almirall Paediatric Spasticity Treatment Introduction 11.3.4 Almirall Revenue in Paediatric Spasticity Treatment Business (2016-2021) 11.3.5 Almirall Recent Development 11.4 Roche 11.4.1 Roche Company Details 11.4.2 Roche Business Overview 11.4.3 Roche Paediatric Spasticity Treatment Introduction 11.4.4 Roche Revenue in Paediatric Spasticity Treatment Business (2016-2021) 11.4.5 Roche Recent Development 11.5 Sanofi 11.5.1 Sanofi Company Details 11.5.2 Sanofi Business Overview 11.5.3 Sanofi Paediatric Spasticity Treatment Introduction 11.5.4 Sanofi Revenue in Paediatric Spasticity Treatment Business (2016-2021) 11.5.5 Sanofi Recent Development 11.6 Saol Therapeutics 11.6.1 Saol Therapeutics Company Details 11.6.2 Saol Therapeutics Business Overview 11.6.3 Saol Therapeutics Paediatric Spasticity Treatment Introduction 11.6.4 Saol Therapeutics Revenue in Paediatric Spasticity Treatment Business (2016-2021) 11.6.5 Saol Therapeutics Recent Development 11.7 US WorldMeds 11.7.1 US WorldMeds Company Details 11.7.2 US WorldMeds Business Overview 11.7.3 US WorldMeds Paediatric Spasticity Treatment Introduction 11.7.4 US WorldMeds Revenue in Paediatric Spasticity Treatment Business (2016-2021) 11.7.5 US WorldMeds Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
SummaryPediatric Spasticity results due to damage of portion of brain or spinal cord which controls the voluntary movement. When pediatric spasticity occurs due to injury or disease, nerve signals do not reach muscles and continuously contract which causes stiffness and tightness which interfere with movement and speech. Table of Contents1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Paediatric Spasticity Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Drug Treatment 1.2.3 Surgical Treatment 1.3 Market by Application 1.3.1 Global Paediatric Spasticity Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Emergency Sugical Center 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Paediatric Spasticity Treatment Market Perspective (2016-2027) 2.2 Paediatric Spasticity Treatment Growth Trends by Regions 2.2.1 Paediatric Spasticity Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Paediatric Spasticity Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Paediatric Spasticity Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Paediatric Spasticity Treatment Industry Dynamic 2.3.1 Paediatric Spasticity Treatment Market Trends 2.3.2 Paediatric Spasticity Treatment Market Drivers 2.3.3 Paediatric Spasticity Treatment Market Challenges 2.3.4 Paediatric Spasticity Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Paediatric Spasticity Treatment Players by Revenue 3.1.1 Global Top Paediatric Spasticity Treatment Players by Revenue (2016-2021) 3.1.2 Global Paediatric Spasticity Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Paediatric Spasticity Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Paediatric Spasticity Treatment Revenue 3.4 Global Paediatric Spasticity Treatment Market Concentration Ratio 3.4.1 Global Paediatric Spasticity Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Paediatric Spasticity Treatment Revenue in 2020 3.5 Paediatric Spasticity Treatment Key Players Head office and Area Served 3.6 Key Players Paediatric Spasticity Treatment Product Solution and Service 3.7 Date of Enter into Paediatric Spasticity Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Paediatric Spasticity Treatment Breakdown Data by Type 4.1 Global Paediatric Spasticity Treatment Historic Market Size by Type (2016-2021) 4.2 Global Paediatric Spasticity Treatment Forecasted Market Size by Type (2022-2027) 5 Paediatric Spasticity Treatment Breakdown Data by Application 5.1 Global Paediatric Spasticity Treatment Historic Market Size by Application (2016-2021) 5.2 Global Paediatric Spasticity Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Paediatric Spasticity Treatment Market Size (2016-2027) 6.2 North America Paediatric Spasticity Treatment Market Size by Type 6.2.1 North America Paediatric Spasticity Treatment Market Size by Type (2016-2021) 6.2.2 North America Paediatric Spasticity Treatment Market Size by Type (2022-2027) 6.2.3 North America Paediatric Spasticity Treatment Market Size by Type (2016-2027) 6.3 North America Paediatric Spasticity Treatment Market Size by Application 6.3.1 North America Paediatric Spasticity Treatment Market Size by Application (2016-2021) 6.3.2 North America Paediatric Spasticity Treatment Market Size by Application (2022-2027) 6.3.3 North America Paediatric Spasticity Treatment Market Size by Application (2016-2027) 6.4 North America Paediatric Spasticity Treatment Market Size by Country 6.4.1 North America Paediatric Spasticity Treatment Market Size by Country (2016-2021) 6.4.2 North America Paediatric Spasticity Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Paediatric Spasticity Treatment Market Size (2016-2027) 7.2 Europe Paediatric Spasticity Treatment Market Size by Type 7.2.1 Europe Paediatric Spasticity Treatment Market Size by Type (2016-2021) 7.2.2 Europe Paediatric Spasticity Treatment Market Size by Type (2022-2027) 7.2.3 Europe Paediatric Spasticity Treatment Market Size by Type (2016-2027) 7.3 Europe Paediatric Spasticity Treatment Market Size by Application 7.3.1 Europe Paediatric Spasticity Treatment Market Size by Application (2016-2021) 7.3.2 Europe Paediatric Spasticity Treatment Market Size by Application (2022-2027) 7.3.3 Europe Paediatric Spasticity Treatment Market Size by Application (2016-2027) 7.4 Europe Paediatric Spasticity Treatment Market Size by Country 7.4.1 Europe Paediatric Spasticity Treatment Market Size by Country (2016-2021) 7.4.2 Europe Paediatric Spasticity Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Paediatric Spasticity Treatment Market Size (2016-2027) 8.2 Asia-Pacific Paediatric Spasticity Treatment Market Size by Type 8.2.1 Asia-Pacific Paediatric Spasticity Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Paediatric Spasticity Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Paediatric Spasticity Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Paediatric Spasticity Treatment Market Size by Application 8.3.1 Asia-Pacific Paediatric Spasticity Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Paediatric Spasticity Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Paediatric Spasticity Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Paediatric Spasticity Treatment Market Size by Region 8.4.1 Asia-Pacific Paediatric Spasticity Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Paediatric Spasticity Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Paediatric Spasticity Treatment Market Size (2016-2027) 9.2 Latin America Paediatric Spasticity Treatment Market Size by Type 9.2.1 Latin America Paediatric Spasticity Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Paediatric Spasticity Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Paediatric Spasticity Treatment Market Size by Type (2016-2027) 9.3 Latin America Paediatric Spasticity Treatment Market Size by Application 9.3.1 Latin America Paediatric Spasticity Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Paediatric Spasticity Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Paediatric Spasticity Treatment Market Size by Application (2016-2027) 9.4 Latin America Paediatric Spasticity Treatment Market Size by Country 9.4.1 Latin America Paediatric Spasticity Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Paediatric Spasticity Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Paediatric Spasticity Treatment Market Size (2016-2027) 10.2 Middle East & Africa Paediatric Spasticity Treatment Market Size by Type 10.2.1 Middle East & Africa Paediatric Spasticity Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Paediatric Spasticity Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Paediatric Spasticity Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Paediatric Spasticity Treatment Market Size by Application 10.3.1 Middle East & Africa Paediatric Spasticity Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Paediatric Spasticity Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Paediatric Spasticity Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Paediatric Spasticity Treatment Market Size by Country 10.4.1 Middle East & Africa Paediatric Spasticity Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Paediatric Spasticity Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Allergan 11.1.1 Allergan Company Details 11.1.2 Allergan Business Overview 11.1.3 Allergan Paediatric Spasticity Treatment Introduction 11.1.4 Allergan Revenue in Paediatric Spasticity Treatment Business (2016-2021) 11.1.5 Allergan Recent Development 11.2 Ipsen Biopharmaceuticals 11.2.1 Ipsen Biopharmaceuticals Company Details 11.2.2 Ipsen Biopharmaceuticals Business Overview 11.2.3 Ipsen Biopharmaceuticals Paediatric Spasticity Treatment Introduction 11.2.4 Ipsen Biopharmaceuticals Revenue in Paediatric Spasticity Treatment Business (2016-2021) 11.2.5 Ipsen Biopharmaceuticals Recent Development 11.3 Almirall 11.3.1 Almirall Company Details 11.3.2 Almirall Business Overview 11.3.3 Almirall Paediatric Spasticity Treatment Introduction 11.3.4 Almirall Revenue in Paediatric Spasticity Treatment Business (2016-2021) 11.3.5 Almirall Recent Development 11.4 Roche 11.4.1 Roche Company Details 11.4.2 Roche Business Overview 11.4.3 Roche Paediatric Spasticity Treatment Introduction 11.4.4 Roche Revenue in Paediatric Spasticity Treatment Business (2016-2021) 11.4.5 Roche Recent Development 11.5 Sanofi 11.5.1 Sanofi Company Details 11.5.2 Sanofi Business Overview 11.5.3 Sanofi Paediatric Spasticity Treatment Introduction 11.5.4 Sanofi Revenue in Paediatric Spasticity Treatment Business (2016-2021) 11.5.5 Sanofi Recent Development 11.6 Saol Therapeutics 11.6.1 Saol Therapeutics Company Details 11.6.2 Saol Therapeutics Business Overview 11.6.3 Saol Therapeutics Paediatric Spasticity Treatment Introduction 11.6.4 Saol Therapeutics Revenue in Paediatric Spasticity Treatment Business (2016-2021) 11.6.5 Saol Therapeutics Recent Development 11.7 US WorldMeds 11.7.1 US WorldMeds Company Details 11.7.2 US WorldMeds Business Overview 11.7.3 US WorldMeds Paediatric Spasticity Treatment Introduction 11.7.4 US WorldMeds Revenue in Paediatric Spasticity Treatment Business (2016-2021) 11.7.5 US WorldMeds Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
QYResearch社の分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2025/04/28 10:26 144.66 円 164.64 円 195.02 円 |